Wellorithm vs Maximus: 50-State Access vs Low Monthly Price
Wellorithm vs Maximus is a direct tradeoff between broader clinician coverage and a lower flat monthly price. Quick verdict: choose Wellorithm if you need licensed clinicians in all 50 states and access to both compounded semaglutide and tirzepatide; choose Maximus if you want a straightforward, low flat rate of $132.99 per month with prescriptions filled through trusted U.S. pharmacies.
Start Wellorithm quiz and check eligibility
How they differ at a glance
Both platforms deliver compounded GLP-1 medications via telemedicine, but they emphasize different strengths. Wellorithm highlights national clinician coverage and offers both compounded semaglutide and tirzepatide. Maximus emphasizes a low flat monthly price and U.S. pharmacy fulfillment. Compounded medications from both providers are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality, a regulatory note both platforms disclose.
Key difference 1: Pricing model and transparency
Maximus publishes a low flat rate of $132.99 per month as its core proposition. The Maximus description repeatedly lists $132.99 per month and calls that a competitive low rate. Wellorithm markets a starting price of $147 and various starting points for different products, but it does not publish a single comprehensive price for every plan; Wellorithm provides personalized quotes after the intake quiz. If predictable monthly cost matters, Maximus is explicit about $132.99 per month. If you prefer a quiz-based quote tied to a chosen compound or plan, Wellorithm requires the intake flow to see your specific cost.
Key difference 2: National clinician coverage
Wellorithm states it has licensed clinicians in all 50 states, which the source identifies as a meaningful advantage for patients in states with limited GLP-1 telehealth options. Maximus is available in all 50 states except Mississippi according to its materials. For patients in hard to serve states, Wellorithm provides broader stated clinician coverage.
Key difference 3: Medication options and pharmacy sourcing
Wellorithm explicitly lists both compounded semaglutide and compounded tirzepatide across injection and oral dissolving formulations. Maximus centers on compounded semaglutide, with limited published detail on tirzepatide availability. Maximus emphasizes that prescriptions are filled through trusted U.S. pharmacies. Wellorithm notes medications are compounded at licensed pharmacies and shipped to the home after virtual consultation. Both platforms use compounded medication formulations and include the regulatory caveat that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Key difference 4: Shipping, guarantees, and refund policies
Wellorithm marketing materials include statements about fast, free shipping and a weight loss guarantee in captured landing page evidence. Wellorithm also advertises promotional starting offers that may apply to first months and different product types. Maximus advertises free priority or expedited shipping and explicitly states that if you are not approved for treatment your medication costs will be fully refunded. Both platforms do not bill insurance and operate on direct-pay models.
Comparison table
| Criteria | Wellorithm | Maximus |
|---|---|---|
| Published starting price | Starting at $147; personalized quote after intake quiz | $132.99 per month flat rate |
| Clinician coverage | Licensed clinicians in all 50 states | Available in all 50 states except Mississippi |
| Medication offerings | Compounded semaglutide and tirzepatide in multiple forms | Compounded semaglutide; tirzepatide availability not clearly published |
| Pharmacy sourcing | Compounded at licensed pharmacies and shipped to home | Filled through trusted U.S. pharmacies with expedited shipping |
| Guarantee or refund | Landing page cites a weight loss guarantee and promotional offers | If not approved for treatment, medication costs will be fully refunded |
Care model and program fit
Both providers use virtual consultations and do not require insurance. Wellorithm frames its process around a 2-minute quiz followed by clinician review and home delivery, with ongoing virtual check-ins for titration. Maximus offers telemedicine approval by licensed doctors and emphasizes a simple direct-pay subscription without clinic visits. Public outcome data and large-scale track records are limited for both platforms in the supplied materials; Wellorithm is described as a smaller platform with fewer public reviews and Maximus is described as a newer platform with a smaller patient base.
Check Wellorithm eligibility and start intake
See Maximus pricing and enroll
Safety and regulatory note
Both sources state compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Each provider describes prescriptions being approved by licensed clinicians or doctors; Wellorithm highlights licensed clinicians in all 50 states and Maximus notes prescriptions are approved by licensed doctors and filled through U.S. pharmacies.
Start Wellorithm enrollment flow
Conclusion and final recommendation
Wellorithm vs Maximus comes down to coverage and drug selection versus transparent low monthly cost. Choose Wellorithm if you need licensed clinicians in all 50 states or want access to both compounded semaglutide and compounded tirzepatide and are comfortable completing an intake quiz for a personalized quote. Choose Maximus if your priority is a predictable low flat rate of $132.99 per month with prescriptions filled through trusted U.S. pharmacies and you primarily want compounded semaglutide.